Clinical Trial Detail

NCT ID NCT01638533
Title Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

lymphoma

Advanced Solid Tumor

chronic lymphocytic leukemia

Therapies

Romidepsin

Age Groups: adult

No variant requirements are available.